Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

JQ1-Loaded Polydopamine Nanoplatform Inhibits c-MYC/Programmed Cell Death Ligand 1 to Enhance Photothermal Therapy for Triple-Negative Breast Cancer

Because the JQ1-loaded PDMNs (PDMN-JQ1) are self-degradable and release JQ1 continuously, this synergistic treatment can lead to remarkable activation of cytotoxic T lymphocytes and induce a strong immune-memory effect to protect mice from tumor re-challenge.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors report a polydopamine nanoplatform loaded with the drug JQ1, which lowers PD-L1 expression and inhibits c-MYC in triple-negative breast cancer models, combined with photothermal therapy. The combination was associated with activation of cytotoxic T lymphocytes and an immune-memory effect protecting mice from tumor re-challenge. The study appears to be preclinical, with findings limited to laboratory and mouse experiments.

Who or what was studied
Triple-negative breast cancer models in mice and cells
Limits stated in the abstract
The abstract does not report human participants, so findings come from preclinical mouse and cell work and may not transfer to patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubs.acs.org.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies